AFC-HD AMS Life Science Co Ltd
TSE:2927
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Componenta Oyj
OMXH:CTH1V
|
FI |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (7.4), the stock would be worth ¥1 483.71 (71% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.3 | ¥866 |
0%
|
| 3-Year Average | 7.4 | ¥1 483.71 |
+71%
|
| 5-Year Average | 7.3 | ¥1 465.18 |
+69%
|
| Industry Average | 8.7 | ¥1 736.94 |
+101%
|
| Country Average | 8.7 | ¥1 739.08 |
+101%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
A
|
AFC-HD AMS Life Science Co Ltd
TSE:2927
|
12.6B JPY | 4.3 | 9.2 | |
| FR |
|
L'Oreal SA
PAR:OR
|
200.9B EUR | 18.7 | 32.8 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
92.3B GBP | 11.3 | 11.2 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.6T INR | 36.8 | 38.3 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.3B GBP | 13.1 | 18.8 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27.6B USD | 14.4 | -155.2 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
16.2B EUR | 8.1 | 17.3 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 10 | 22.6 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR | 38.5 | 63.9 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -6 373.4 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
815.9B INR | 32.3 | 44.3 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.7 |
| Median | 8.7 |
| 70th Percentile | 12.2 |
| Max | 214 699 781.2 |
Other Multiples
AFC-HD AMS Life Science Co Ltd
Glance View
AFC-HD AMS Life Science Co., Ltd. engages in the manufacture of health food and cosmetics. The company is headquartered in Shizuoka-Shi, Shizuoka-Ken and currently employs 793 full-time employees. The company went IPO on 2005-03-03. The firm is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The firm operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The firm is also engaged in the management of restaurants through subsidiary.
